Skip to main content
OpenTrials
Completed

NCT Number: NCT07638930

Colibricare Efficacy on Oral Surgical Procedures/Extraction Wound and Gingiva Retraction

In this randomized, three-arm trial, 120 patients undergoing wisdoms' extractions were assigned to control (gauze pressure application), commercial sponge, or Coli-sorb® groups. Outcomes included time to hemostasis, ease of placement, pain (VAS), facial swelling, and wound healing, assessed on days 1, 7, and 6 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bleeding Hemorrhage Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cario University

Cairo, Cairo Governorate, 12515, Egypt

About this study

Colisorb® is a safe, efficient, and biocompatible hemostatic agent, providing rapid bleeding control, reduced pain, and enhanced healing, outperforming conventional gauze and commercial alternatives.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • require wisdoms removal

Exclusion criteria

  • systemic diseases affecting healing

Treatment and study plan

wisdoms' surgical extractions

Procedure

surgical removal of wisdoms

Primary outcomes

  1. pain

    Time frame: 7 days

    VAS visual analogue scale grades (0-10)

Secondary outcomes

  1. closure of the wound

    Time frame: 15 days

    binary method yes or no

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Evaluating the Hemostatic Efficacy and Comparing the Clinical Performance of Colibricare; A Newly Devel-oped Dental Sponges on Oral Surgical Procedures/Extraction Wound and Gingiva Retraction to Other Conven-tional Products (Randomized Clinical Trail)

Important dates

Study start
2022
Primary completion
2022
Study completion
2026
First posted
Jun 10, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.